Today’s guest: Karen DeSalvo | Chief Health Officer at Google Health and Professor of Medicine and Population Health at the University of Texas at Austin Dell Medical School Greg and Karen talk about how our model for reimbursing healthcare, telehealth and the social […]
Our Blog
Why innovation is a MUST when treating the next generation – A Conversation with Margaret Laws of HopeLab
Today’s guest: Margaret Laws | CEO of Hopelab Greg and Margaret discuss the needs & expectations of children and adolescents as they relate to healthcare, and how current models of care are actively being challenged by organizations like HopeLab. Important Links: […]
Are laws finally catching up with innovation in healthcare? A Conversation with Nate Lacktman of Foley and Lardner
Today’s guest: Nate Lacktman | Partner and Chair of Telemedicine & Digital Health Industry Team at Foley & Lardner Greg and Nate talk about how law and policy can either help or hinder necessary innovation in healthcare, and why he’s optimistic […]
Medicine unbound by space and time – A Conversation with Joe Kvedar, MD of Partners Healthcare
Today’s guest: Joe Kvedar, MD | Vice President, Connected Health at Partners Healthcare Greg and Joe talk about the evolution of the concept of “telehealth” into one that already is a part of mainstream care & will soon break down all […]
Can genomics help focus scarce healthcare resources on the people who need it most – before they need it?
Today’s Guest: James Lu, MD, PhD | Co-Founder and SVP for Applied Genomics at Helix Greg and James talk about the importance of clinical quality sequencing personal genomics and consider the possibility of treating genetic testing as a foundational diagnostic, enabling […]
Unlocking value for the patient in the consumer genomics market – a conversation with Robin Thurston
Today’s Guest: Robin Thurston | CEO of Helix Greg and Robin break down the differences between genotyping and next-gen sequencing, how we move beyond genealogy-only use cases, and why that distinction is so important for impacting value for patients and consumers. […]